Clinical Trial Update: Stiripentol for the Treatment of Refractory Status Epilepticus

View source ↗

Summary

Clinical trial evaluating stiripentol for refractory status epilepticus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Status Epilepticus

Drugs mentioned

• Stiripentol (stiripentol)

Snippet

Sponsor: University Hospital Marburg | Conditions: Status Epilepticus | Status: COMPLETED